Botensilimab Not Yet Recruiting Phase 3 Trials for Gastric Cancer / Microsatellite Instability-high (MSI-H) / Metastatic Cancer / Advanced Malignant Neoplasm Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT06346197Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas